Characteristics of coronary artery disease in chronic kidney disease

Hideki Fujii1, Keiji Kono2, Shinichi Nishi2

  • 1Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan. fhideki@med.kobe-u.ac.jp.

Insights

Cardiorenal syndrome links chronic kidney disease (CKD) and cardiovascular disease (CVD). Understanding these complex links, including endothelial dysfunction and vascular calcification, is vital for preventing CVD progression in CKD patients.

Area of Science:

  • Nephrology
  • Cardiology
  • Internal Medicine

Background:

  • Cardiovascular disease (CVD) is a leading cause of mortality in patients with chronic kidney disease (CKD).
  • The interplay between CKD and CVD is increasingly recognized, leading to the concept of cardiorenal syndrome.
  • Preventing CVD progression is critical for improving outcomes in CKD patients.

Purpose of the Study:

  • To examine the complex relationship between CKD and CVD.
  • To highlight key factors contributing to CVD in CKD patients, such as coronary artery disease (CAD) and myocardial injury.
  • To emphasize the importance of understanding underlying mechanisms for better prognosis.

Main Methods:

  • Review of existing literature on CKD, CVD, and cardiorenal syndrome.
  • Analysis of factors like endothelial dysfunction (measured by coronary flow reserve - CFR) and coronary artery calcification.
  • Consideration of both traditional and non-traditional risk factors for CVD in CKD.

Main Results:

  • Decreased CFR, an indicator of endothelial dysfunction, is linked to adverse coronary events and mortality and declines with worsening kidney function.
  • Vascular calcification, particularly in CKD, impacts coronary atherosclerotic plaque stability.
  • Both traditional and CKD-specific non-traditional risk factors contribute significantly to CVD progression.

Conclusions:

  • The mechanisms driving CVD progression in CKD are complex and multifactorial.
  • Clarifying these mechanisms is essential for developing effective strategies to improve cardiovascular outcomes in CKD patients.
  • Further research into cardiorenal syndrome is crucial for patient management.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.0K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
415
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
697
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
613
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
246
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
387